SCHEMBL958719

SCHEMBL958719

O=C(NCCN1CCCC1)c1cccc(-c2cccc(Oc3cccc(Cl)c3Cl)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.54
ATR Q13535 2/20 0.48
DRD4 P21917 4/20 0.48
DRD2 P14416 3/20 0.48
ERN1 O75460 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
IKBKB O14920 1/20 0.47
DRD3 P35462 2/20 0.47
ADORA2A P29274 1/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45
PDE4B Q07343 1/20 0.45
PIM1 P11309 1/20 0.45
PIM2 Q9P1W9 1/20 0.45
SMYD2 Q9NRG4 1/20 0.45
CAMK2D Q13557 1/20 0.45
ALDH1A1 P00352 1/20 0.44
SCN9A Q15858 1/20 0.44
MCHR1 Q99705 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL957882 0.88 MAP4K4 (0.54) MAP4K4ATRERN1MEN1KMT2A
SCHEMBL958254 0.85 MAP4K4 (0.54) MAP4K4ATRERN1MEN1KMT2A
SCHEMBL961526 0.85 MAP4K4 (0.56) MAP4K4ATRDRD4DRD2ERN1
SCHEMBL963967 0.80 MAP4K4 (0.54) MAP4K4ATRDRD4ERN1MEN1
SCHEMBL963739 0.79 F10 (0.62) MAP4K4ATRERN1MEN1KMT2A
SCHEMBL961442 0.77 MRGPRX4 (0.50) MEN1KMT2A
SCHEMBL959310 0.76 L3MBTL1 (0.52) ERN1MEN1KMT2AALDH1A1SCN9A
SCHEMBL959544 0.76 GPR52 (0.45) MAP4K4MEN1KMT2AMCHR1
SCHEMBL12918939 0.76 MAP4K4 (0.51) MAP4K4ATRERN1MEN1KMT2A
SCHEMBL960760 0.74 GPR52 (0.53) MAP4K4ATRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 MAP4K4 2519/4885ATR 3271/4885DRD4 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.